Healthy Transitions: Menopause Effect on Obesity, Energy Balance, and Insulin - Full Text View

Sponsors and Collaborators:	Pennington Biomedical Research Center National Institutes of Health (NIH)
Information provided by:	Pennington Biomedical Research Center
ClinicalTrials.gov Identifier:	NCT00412269

Purpose

The purpose of this study is to determine the effect of menopause on obesity, energy balance, and insulin in postmenopausal, obese women.

Condition
Menopause

MedlinePlus related topics: Menopause Obesity

Drug Information available for: Insulin

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cohort, Prospective
Official Title:	Healthy Transitions: Menopause Effect on Obesity, Energy Balance, and Insulin

Further study details as provided by Pennington Biomedical Research Center:

Biospecimen Retention: None Retained

Biospecimen Description:

Enrollment:	160
Study Start Date:	February 1998
Study Completion Date:	March 2007
Primary Completion Date:	March 2007 (Final data collection date for primary outcome measure)

Detailed Description:

The effect of menopause on body composition and cardiovascular risk in healthy caucasian women has been the subject of much study. In contrast, there are few data available on menopause in African-American women. Since menopause is associated with potentially preventable health risks in women, this proposal is aimed at characterizing the perimenopausal period in terms of body fat, energy balance, and insulin action in both caucasian and African-American women.

The study will address 4 general hypotheses:

Menopause increases both total and visceral abdominal fat
Changes in body composition and body weight at menopause are mediated, at least in part by changes in 24-hour energy expenditure and/or food intake
Menopause results in decreased insulin sensitivity that may predispose certain women to develop diabetes later in life
African-American women may respond to the shifts in reproductive hormones at menopause differently than caucasian women.

Eligibility

Ages Eligible for Study:	47 Years to 52 Years
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	Yes
Sampling Method:	Probability Sample

Study Population

Pennington Biomedical Research Center is located in Baton Rouge, Louisiana, adjacent to the medical services district of the Regional Medical Center. The city of Baton Rouge is the home of state government, the 27,000-student Louisiana State University, the 9,000-student Southern University and a large petrochemical industry. Lacking the traditional active urban "downtown", the region is characterized by the suburban pattern of single family subdivisions and small apartment complexes. The population within a 7 parish (i.e. county) area is 635,202. The population of East Baton Rouge Parish is 380,105 with an ethnic distribution of 62% Caucasian, 35% African-American, 1% Asian, and <1% Native American and Hispanic. There are 34,885 people over age 65 and 251,586 between ages 16-65 yr.

Criteria

Inclusion Criteria:

Age 47-52 yr, at time of enrollment
Body Mass Index 25-40
Normal oral glucose tolerance test by National Diabetes Data Group criteria
Premenopausal, defined by FSH levels <30mIU/ml and at least 5 menstrual periods in the last 6 months
Able to confirm ethnic heritage of past 2 generations in family

Exclusion Criteria:

hypertension or hypercholesterolemia requiring medication
regular use of medications that influence glucose tolerance
use of oral contraceptives within the past 6 months
history of myocardial infarction or significant coronary vascular disease or stroke
history of endocrine, kidney, or liver disease or malignancy
any psychopathology, including eating disorders, substance abuse, and major depression
unable to complete longitudinal study commitment, including anticipating moving out of the area within the next 5 years.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00412269

Locations

United States, Louisiana
Pennington Biomedical Research Center
Baton Rouge, Louisiana, United States, 70808

Sponsors and Collaborators

Pennington Biomedical Research Center

National Institutes of Health (NIH)

Investigators

Principal Investigator:

Steven R Smith, M. D.

Pennington Biomedical Research Center

More Information

Publications indexed to this study:

Lovejoy JC, Champagne CM, de Jonge L, Xie H, Smith SR. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes (Lond). 2008 Jun;32(6):949-58. Epub 2008 Mar 11.

Responsible Party:	Pennigton Biomedical Research Center ( Steven R Smith )
Study ID Numbers:	PBRC97022
Study First Received:	December 14, 2006
Last Updated:	February 15, 2008
ClinicalTrials.gov Identifier:	NCT00412269
Health Authority:	United States: Institutional Review Board

Keywords provided by Pennington Biomedical Research Center:

Insulin Sensitivity
Total abdominal fat
Visceral abdominal fat
Reproductive Hormones

Menopause
Diabetes
Fat Distribution
Sex Hormones

Study placed in the following topic categories:

Obesity
Diabetes Mellitus
Healthy
Insulin
Menopause

Additional relevant MeSH terms:

Hypoglycemic Agents
Physiological Effects of Drugs
Pharmacologic Actions

ClinicalTrials.gov processed this record on January 14, 2009